Industry
Almirall, SAS
Total Trials
6
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
Failure Rate
16.7%
1 terminated/withdrawn out of 6 trials
Success Rate
66.7%
-19.8% vs industry average
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 4
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 4(2)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT07273656Phase 3Not Yet Recruiting
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Role: collaborator
NCT06026358Phase 4Withdrawn
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands
Role: collaborator
NCT05010538Completed
Sarecycline Truncal Acne Safety and Efficacy Response
Role: collaborator
NCT02075697Unknown
Spanish Registry of Systemic Treatments in Psoriasis
Role: collaborator
NCT00920348Unknown
The Canadian Cohort Obstructive Lung Disease
Role: collaborator
NCT00462319Phase 4Completed
ARTIST: ARThrose Intervention STandardisée
Role: lead
All 6 trials loaded